Toggle navigation
Home
Search
Services
Blog
Contact
About
Alzheimers Disease Inhibitor Protein & Cognate Protease
Cordell, Barbara L.
California Biotechnology, Inc., Mountain View, CA, United States
Search 9 grants from Barbara Cordell
Search grants from California Biotechnology, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Project 3: Intercepting Renal Damage following Skin Exposure to Arsenicals
Targeted genomic characterization of uncultured bacteria from the human microbiot
Bcl-2 Family Protein and Apoptosis in Schizophrenia
Culture Specific Models of Men's Aggression
Biological Determinants of Environmental Airway Injury
Recently added grants:
Patient-Specific Strategies for Capsular Repair Following Shoulder Dislocations
Transcriptomic and epigenomic landscape of neurodegenerative disease models
A large animal model to elucidate the role of LGR5 stem cells in cancer
Characterizing malaria vector competence among natural populations of Anopheles
Optical nanosensor for 3D force sensing in intact tissues of live animals
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AG009171-03
Application #
2050615
Study Section
Special Emphasis Panel (SSS (B3))
Project Start
1992-01-05
Project End
1995-12-31
Budget Start
1993-01-01
Budget End
1995-12-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
California Biotechnology, Inc.
Department
Type
DUNS #
City
Mountain View
State
CA
Country
United States
Zip Code
94043
Related projects
NIH 1993
R44 AG
Alzheimers Disease Inhibitor Protein & Cognate Protease
Cordell, Barbara L. / California Biotechnology, Inc.
NIH 1992
R44 AG
Alzheimers Disease Inhibitor Protein & Cognate Protease
Cordell, Barbara L. / Scios, Inc.
Comments
Be the first to comment on Barbara Cordell's grant